Date:
19 May 2026 from 08:30 to 09:45
Language:
English
Location:
St. Alban-Graben 3, Basel or remotely via Teams
Registration:
Agenda
08:15 - 08:30 a.m.
08:30 - 09:30 a.m.
09:30 - 09:45 a.m.
From 09:45 a.m.
Reception (for the participants on site)
Presentation
Q&A and discussion
Coffee, croissants and networking (for participants on site)
Abstract
Change is hard. Moving users from a much‑loved (but increasingly insufficient) in‑house tool to an off‑the‑shelf solution is even harder. This presentation takes the audience through that journey: the migration of approximately 400 scientists and technicians from an in‑house inventory management platform to a successful deployment of Mosaic.
It describes how what initially started as a software project evolved into a truly collaborative initiative between research and IT, and how users were engaged and their initial reluctance overcome. The result is a Sample Management platform that now serves as a solid foundation for future ambitions within the company.
The journey was not without challenges. Adjustments were required along the way, and many lessons were learned, which will be shared. The presentation concludes with a set of principles to be applied to future change projects—principles that the audience may also find helpful.
Our Speaker
Stuart Moodie
Sample Management Lead, Therapeutics Discovery at Novo Nordisk A/S
Stuart leads the Compound Management Team, safeguarding and supplying compounds to research projects across the organisation. Alongside this, he plays an advocacy role, promoting best practice in sample management, tracking, and the development of digital strategies to support these activities.
Originally from the UK, Stuart moved to Denmark six years ago to join Novo Nordisk, where he worked as a Scientific Software Architect before transitioning into his current lab-based role. He brings over 25 years of experience delivering software solutions for scientists.
His career spans both academia (the European Bioinformatics Institute and the University of Edinburgh) and the pharmaceutical industry, including roles at GSK, Pfizer, and AstraZeneca. A consistent theme throughout his career has been bridging the gap between IT and science, with a strong focus on practical delivery and getting things done.